Skip to main content
Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
183.38
+2.71 (1.50%)
At close: Apr 28, 2026, 4:00 PM EDT
183.38
0.00 (0.00%)
After-hours: Apr 28, 2026, 6:29 PM EDT

Biogen Revenue by Segment
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Multiple Sclerosis
4.19B 4.18B 4.23B 4.35B 4.45B 4.55B 4.61B 4.66B
Multiple Sclerosis Growth
-5.76% -8.10% -8.37% -6.70% -6.60% -7.90% -10.62% -14.15%
Other
2.89B 2.85B 2.64B 2.49B 2.39B 2.42B 2.47B 2.59B
Other Growth
20.78% 17.43% 7.12% -3.89% -10.48% -2.92% 1.98% 18.45%
Rare Disease
2.17B 2.14B 2.13B 1.99B 1.87B 1.82B 1.72B 1.74B
Rare Disease Growth
16.58% 17.34% 23.36% 13.99% 4.21% 2.78% -2.26% -2.77%
Biosimilars
761.30M 761.10M 777.50M 793.60M 779.80M 777.50M 774.50M 770.00M
Biosimilars Growth
-2.37% -2.11% 0.39% 3.06% 3.07% 3.68% 3.38% 2.52%

Revenue by Geography
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
International
3.82B 3.87B 3.98B 3.98B 3.96B 4.02B 4.01B 4.11B
International Growth
-3.44% -3.72% -0.65% -3.14% -5.18% -6.11% -8.77% -9.25%
Other Geographic
2.73B 2.74B 2.59B 2.46B 2.39B 2.42B 2.47B 2.59B
Other Geographic Growth
14.22% 13.22% 4.90% -4.87% -10.48% -2.92% 1.98% 18.45%
United States
935.30M 941.10M 753.80M 831.50M 813.00M 846.70M 746.10M 848.10M
United States Growth
15.04% 11.15% 1.03% -1.96% 2.79% 5.71% 6.37% -0.18%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.